DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant - Wikidata - awgldk - TriplyDB

DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant

DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant

http://www.wikidata.org/entity/Q28542668

about

Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.Differential Immune Response against Recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 Proteins in BALB/c Mice.Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a model Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani.Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.Immune Response and Protective Efficacy of a Heterologous DNA-Protein Immunization with Leishmania Superoxide Dismutase B1.

P2860

Q27318412-8BF7F3FA-226D-4F2C-9938-88E03114D370 Q35687444-C9E70B78-9383-4656-B241-D27AB39CF2BD Q36035026-75A9B29E-2335-41C2-8174-5D38545B537E Q36294004-724A1070-6BDC-4FE2-BF67-8A9586609F92 Q39220191-B4B0B09F-90DD-4F2F-BE36-B83C60C7DA7D Q40217417-A22731B8-DFE0-48E9-A6A7-3C3DFBC3E061 Q46464854-46D4685C-2274-4267-814A-B77761038FC4 Q47429358-74F486E9-3829-44BD-914D-A5E527044641 Q48189111-E64C7894-3135-445A-9177-5D67256556FC

P2860

DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant

http://www.wikidata.org/entity/Q28542668

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

DNA-protein immunization using ...... timulating factor DNA adjuvant

@ast

DNA-protein immunization using ...... timulating factor DNA adjuvant

@en

DNA-protein immunization using ...... timulating factor DNA adjuvant

@nl

type

label

DNA-protein immunization using ...... timulating factor DNA adjuvant

@ast

DNA-protein immunization using ...... timulating factor DNA adjuvant

@en

DNA-protein immunization using ...... timulating factor DNA adjuvant

@nl

prefLabel

DNA-protein immunization using ...... timulating factor DNA adjuvant

@ast

DNA-protein immunization using ...... timulating factor DNA adjuvant

@en

DNA-protein immunization using ...... timulating factor DNA adjuvant

@nl

P1433

Q28542668-FB03AFB3-F61F-42BD-AD0F-FA7E485A514E

P1476

Q28542668-85B66464-903B-4199-83E0-3209FB41B828

P2093

Q28542668-34CE983D-857C-49C0-9193-AD1429974381

Q28542668-BE6DF553-A305-4118-948C-36968740C148

P2860

Q28542668-016F0893-20B4-4009-AC53-C46E1D25603F

Q28542668-02142616-D18F-4516-8AD4-2A967676696C

Q28542668-13020C58-D89B-41CA-B81C-3B1A66ACE77B

Q28542668-1808F6AD-0915-44FC-8CEC-570C85617B01

Q28542668-1FE852FB-EE49-4A6A-991B-78676CE30F9B

Q28542668-343E2780-0404-4243-96BC-87FAFF360E3C

Q28542668-34F21C38-509E-4FD3-8810-FDE425B66A48

Q28542668-41E875E3-4F46-4CC0-857D-CE86D4EEAE10

Q28542668-4BF542A8-A3D9-4532-A9EE-3F0932BE270E

Q28542668-5141CBDC-494C-4F9B-AC2F-686566A77028

P304

Q28542668-F97E12BC-8D5C-4FF4-85D2-082D230DBF9D

P31

Q28542668-9A9A106B-795C-41E0-A501-621835991EA8

P356

Q28542668-DAE025B6-6FC6-4C54-9348-3C1E0151AAF1

P407

Q28542668-7AB7D635-DE98-4D2F-8472-6CBDF7D097EA

P433

Q28542668-C1150BF0-2083-47AD-823C-0B2AA4F47D05

P478

Q28542668-051E6AA0-7F7D-4E18-896B-28C8EE8F507D

P50

Q28542668-286BFEBA-B626-4ECF-A8C1-AF3E41356A65

P577

Q28542668-71F44236-CD7A-4F45-8191-B2870FE2D1B2

P5875

Q28542668-36AEFF45-BC7A-4623-B5C3-9E7B026C5948

P698

Q28542668-02D31E6A-4A1C-4E21-B16D-B1CD73CE69D1

P921

Q28542668-5F478B8E-CEF0-4D1A-9A6D-956994D51635

Q28542668-7C89B5C2-4437-4E71-9E6F-D5EE4B1C26ED

Q28542668-BDB7790F-0E92-47C1-8F9D-4FD11418518B

P932

Q28542668-0EF3C977-6AA5-4F3A-945D-654D395391C0

P356

JOURNAL.PNTD.0003391

P1433

PLOS Neglected Tropical Diseases

P1476

DNA-protein immunization using ...... timulating factor DNA adjuvant

@en

P2093

Abebe Genetu Bayih

http://www.w3.org/2001/XMLSchema#string

Lashitew Gedamu

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Identification, sequencing and expression of peroxidoxin genes from Leishmania aethiopica.

N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line.

Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity

Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.

Leishmaniasis: current status of vaccine development

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.

P304

e3391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0003391

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269717963

http://www.w3.org/2001/XMLSchema#string

P698

25500571

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

4263403

http://www.w3.org/2001/XMLSchema#string